TABLE 1.
Comparison of Clinical and Radiologic Characteristics, Including PCL Prevalence, of Patients With ADPKD and Control Patients
| Characteristic* | ADPKD Group (n = 271) | Control Group (n = 271) | P |
|---|---|---|---|
| Age at first MRI, mean (SD), y | 42 (12) | 42 (12) | >0.99 |
| Age of PCL patients, mean (SD), y | 43 (12) | 50 (9) | <0.001 |
| Sex, male, n (%) | 109 (40) | 109 (40) | >0.99 |
| White race/ethnicity, n (%) | 247 (91) | 228 (84) | 0.02 |
| eGFR with CKD-EPI, mean (SD), mL/min/1.73 m2 | 69 (30) | 94 (28) | 0.001 |
| MRI with gadolinium, n (%) | 104 (38) | 244 (90) | 0.03 |
| Presence of ≥1 PCL, n (%) | 52 (19) | 28 (10) | 0.03 |
| No. PCL, mean (SD) | 1.6 (1.1) | 1.6 (1.2) | 0.90 |
| PCL size, mean (SD), mm | 6.4 (4.1) | 6.2 (3.1) | 0.80 |
| PCL location in pancreas (n = 52), n (%) | |||
| Head | 17 (33) | 11 (42) | |
| Body | 12 (23) | 6 (21) | |
| Tail | 12 (23) | 5 (18) | |
| Uncinate/neck | 1 (2) | 1 (4) | |
| Multiple | 10 (19) | 5 (17) | |
| No. PCL, n (%) | |||
| 0 | 219 (81) | 244 (90) | |
| 1 | 37 (14) | 16 (6) | |
| 2 | 7 (3) | 7 (3) | |
| 3–10 | 8 (3) | 5 (2) |
*
Values are presented as number and percentage of patients unless specified otherwise.
ADPKD indicates autosomal dominant polycystic kidney disease; CKD-EPI, chronic kidney disease–epidemiology collaboration; eGFR, estimated glomerular filtration rate; MRI, magnetic resonance imaging; PCL, pancreatic cyst lesion.